Lobbying Filing Details

Total Spending

$50,000

Activities

4

Lobbyists

7

Gov't Entities

8

Filing Information
Filing UUID:
af35af92-3276-4307-a9c3-701d463331ab
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 17, 2026 at 2:36 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Mathew Lapinski
Registrant
CROSSROADS STRATEGIES, LLC

lobbying firm

Washington, District of Columbia
Client
VERTEX PHARMACEUTICALS INCORPORATED

biopharmaceutical company

Massachusetts, United States of America
Lobbying Activities (4)
Activity 1
Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Lobbyists (7)
  • MATHEW LAPINSKI
  • JASON BENJAMIN VAN PELT
  • CHRIS J MILLER
  • BRITTANY JOHNSON HERNANDEZ
  • MS. CHERYL LYNN JAEGER
  • MS. IVELISSE ALEXANDRA PORROA-GARCIA
  • MR. STEPHEN THOMAS VOLJAVEC
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medical/Disease Research/Clinical Labs

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

Lobbyists (7)
  • MATHEW LAPINSKI
  • JASON BENJAMIN VAN PELT
  • CHRIS J MILLER
  • BRITTANY JOHNSON HERNANDEZ
  • MS. CHERYL LYNN JAEGER
  • MS. IVELISSE ALEXANDRA PORROA-GARCIA
  • MR. STEPHEN THOMAS VOLJAVEC
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Medicare/Medicaid

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Lobbyists (7)
  • MATHEW LAPINSKI
  • JASON BENJAMIN VAN PELT
  • CHRIS J MILLER
  • BRITTANY JOHNSON HERNANDEZ
  • MS. CHERYL LYNN JAEGER
  • MS. IVELISSE ALEXANDRA PORROA-GARCIA
  • MR. STEPHEN THOMAS VOLJAVEC
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
Activity 4
Trade (domestic/foreign)

Policies impacting the manufacturing pharmaceutical products including tariffs.

Lobbyists (2)
  • MS. CHERYL LYNN JAEGER
  • MR. STEPHEN THOMAS VOLJAVEC
Government Entities (1)
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.